Keros Therapeutics, Inc.
KROS | US
Overview
Corporate Details
- ISIN(s):
- US4923271013
- LEI:
- Country:
- United States of America
- Address:
- 1050 WALTHAM STREET, SUITE 302, 2421 LEXINGTON
- Website:
- https://www.kerostx.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Keros Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Keros Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Keros Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops custom genetically modified preclinical models for biopharma and academic research.
France
ALGEN
France
ALGEN
A clinical-stage firm developing non-viral gene therapies for cancer and diabetes.
United States of America
GNPX
United States of America
GNPX
A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.
Poland
GX1
Poland
GX1
Developing vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.
United States of America
GOVX
United States of America
GOVX
Clinical-stage biopharma developing mebufotenin therapies for psychiatric disorders.
United States of America
GHRS
United States of America
GHRS
Develops fusion protein biologics for oncology, allergic, and metabolic diseases.
South Korea
358570
South Korea
358570
A cell programming platform offering R&D services for pharma, agriculture, food, and chemicals.
United States of America
DNA
United States of America
DNA
A biotech company that detects multiple cancers early with a single blood test.
United States of America
GRAL
United States of America
GRAL
Develops TriKE® immunotherapies engaging NK cells to treat hematologic and solid tumor cancers.
United States of America
GTBP
United States of America
GTBP
Clinical-stage biotech developing drugs to prevent acute kidney injury during open-heart surgery.
Sweden
GUARD
Sweden
GUARD